Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

01.04.2014 | perspective | Ausgabe 7-8/2014 Open Access

Wiener klinische Wochenschrift 7-8/2014

Reporting bias in trials of volume resuscitation with hydroxyethyl starch

Zeitschrift:
Wiener klinische Wochenschrift > Ausgabe 7-8/2014
Autor:
MD Prof. Christian J. Wiedermann

Summary

The possibility of renal damage by hydroxyethyl starch has become the focus of intensive dispute based on the findings of published large trials. The aim of this narrative review is to analyze outcome reporting bias in the literature on volume resuscitation, focusing on selective outcome reporting in published randomized and observational trials with “modern” hydroxyethyl starch as therapeutic intervention. Three recent publications claimed to confirm renal safety of hydroxyethyl starch 130/0.4 for indications in severe sepsis, trauma, and critical illness, respectively. Selective outcome reporting was identified in these studies including underreporting of side effects and change of primary study outcomes. In conclusion, selective outcome reporting bias is identified in recent publications of clinical trials on volume resuscitation with HES.
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 7-8/2014

Wiener klinische Wochenschrift 7-8/2014 Zur Ausgabe

MUW researcher of the month

Researcher of the Month April 2014

gesellschaft der ärzte in wien

gesellschaft der ärzte in wien